4.2.4. Preparation of methyl 5-((3,7-dihydroxy-1-methyl-6-oxo-6H-benzo[c]chromen-9-yl)oxy)pentanoate (8)

LA Luis G. Addante-Moya
AA Antonio Abad-Somovilla
AA Antonio Abad-Fuentes
CA Consuelo Agulló
JM Josep V. Mercader
ask Ask a question
Favorite

A 3 M solution of HCl in MeOH (150 µL, 0.450 mmol) was added to a solution of biaryl compound 7 (26.1 mg, 0.050 mmol) in anhydrous MeOH (1.5 mL) and the reaction mixture was stirred at rt for 22 h. After concentration under vacuum, the residue was dissolved in anhydrous CH2Cl2 (4 mL) and treated with trifluoroacetic acid (430 µL). Following stirring for 20 h at rt, thin layer chromatography showed the formation of a single compound and all the volatiles were removed under vacuum, using CHCl3 to co-evaporate the last traces of TFA. The obtained residue was purified by chromatography, using CHCl3 as eluent, to give benzochromenone derivative 8 (18.1 mg, 97%) as a white solid. 1H NMR (300 MHz, DMSO-d6) δ 11.79 and 10.33 (each s, 1H each, 2×OH), 7.13 (d, J = 2.2 Hz, 1H, H-10), 6.69 (d, J = 2.6 Hz, 1H, H-2), 6.61 (d, J = 2.6 Hz, 1H, H-4), 6.55 (d, J = 2.2 Hz, 1H, H-8), 4.11 (t, J = 5.9 Hz, 2H, H2-5), 3.59 (s, 3H, OCH3), 2.68 (s, 3H, CH3), 2.41 (t, J = 7.0 Hz, 2H, H2-2), 1.85–1.56 (m, 4H, H2-3 and H2-4); 13C NMR (75 MHz, DMSO-d6) δ 173.2 (CO2CH3), 165.5 (CO), 164.6 (C-9), 164.1 (C-7), 158.5 (C-3), 152.6 (C-4a), 138.4 (C-1), 137.7 (C-10a), 117.5 (CH2-2), 108.8 (C-10b), 103.6 (CH-10), 101.6 (CH-4), 99.5 (CH-8), 98.3 (C-6a), 67.8 (CH2-5), 51.2 (CO2CH3), 32.8 (CH2-2), 27.8 (CH2-4), 25.0 (CH3), 21.1 (C-3); HRMS (TOF, ES+) m/z calculated for C20H21O7 [M + H]+ 373.1282; found 373.1278.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A